BRCA2 and prostate carcinoma: In addition, prostate cancer patients with a pathogenic germline variant in the BRCA2 gene have a higher risk of developing metastases and dying from prostate cancer at an early age [8, 57], and they have a higher risk of developing breast cancer [58].